Suchergebnisse - "Dodd, Lori E"

PubPharm (11)

1

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19 : A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

enthalten in: Annals of internal medicine | 2024

von Paules, C. | Wang, J. | Tomashek, K. | +18

2

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1 : Implications for Critical Care Resource Utilization

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Fintzi, J. | Bonnett, T. | Sweeney, D. | +7

3

Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19) : A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Paules, C. | Gallagher, S. | Rapaka, R. | +13

4

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

enthalten in: The New England journal of medicine | 2021

von Kalil, A. | Patterson, T. | Mehta, A. | +158

CommentIn: N Engl J Med. 2021 Mar 4;384(9):867-869. - PMID 33657299

5

Remdesivir for the Treatment of Covid-19 - Final Report

enthalten in: The New England journal of medicine | 2020

von Beigel, J. | Tomashek, K. | Dodd, L. | +138

CommentIn: N Engl J Med. 2020 Nov 5;383(19):1886-1887. - PMID 32459913

6

Endpoints for randomized controlled clinical trials for COVID-19 treatments

enthalten in: Clinical trials (London, England) | 2020

von Dodd, L. | Follmann, D. | Wang, J. | +12

CommentIn: Clin Trials. 2021 Apr;18(2):263-264. - PMID 33322940

7

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

enthalten in: The New England journal of medicine | 2019

von Mulangu, S. | Dodd, L. | Davey, R. | +150

CommentIn: N Engl J Med. 2019 Dec 12;381(24):2365-2366. - PMID 31774948

8

Statistical considerations for a trial of Ebola virus disease therapeutics

enthalten in: Clinical trials (London, England) | 2016

von Proschan, M. | Dodd, L. | Price, D.

CommentIn: Clin Trials. 2016 Aug;13(4):454-5. - PMID 27136948

9

A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma

enthalten in: BMC infectious diseases | 2016

von Colombo, R. | Fiorentino, C. | Dodd, L. | +6

10

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone

enthalten in: Antiviral research | 2012

von Altmann, S. | Smith, A. | Dyall, J. | +5